Table of Content

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Foot and Mouth Disease Vaccine Market

4. Market Overview
    4.1. Introduction
        4.1.1. Segment Definition
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Foot and Mouth Disease Vaccine Market Analysis and Forecast, 2017-2031
        4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights
    5.1. Foot and Mouth Disease Overview
    5.2. Disease Prevalence & Incidence Rate Overview
    5.3. Regulatory Scenario
    5.4. Key Industry Events
    5.5. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long-term Impact)

6. Global Foot and Mouth Disease Vaccine Market Analysis and Forecast, by Type
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Type, 2017-2031
        6.3.1. Aluminum Hydroxide and Saponin Vaccines
        6.3.2. Oil-based Vaccines
            6.3.2.1. Single-oil Emulsion
            6.3.2.2. Double-oil Emulsion
    6.4. Market Attractiveness, by Type

7. Global Foot and Mouth Disease Vaccine Market Analysis and Forecast, by Animal
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by Animal, 2017-2031
        7.3.1. Cattle
        7.3.2. Sheep and Goat
        7.3.3. Swine/Pig
        7.3.4. Others
    7.4. Market Attractiveness, by Animal

8. Global Foot and Mouth Disease Vaccine Market Analysis and Forecast, by Distribution Channel
    8.1. Introduction & Definition
    8.2. Key Findings/Developments
    8.3. Market Value Forecast, by Distribution Channel, 2017-2031
        8.3.1. Veterinary Clinics
        8.3.2. Government Institutions
        8.3.3. Others
    8.4. Market Attractiveness, by Distribution Channel

9. Global Foot and Mouth Disease Vaccine Market Analysis and Forecast, by Region
    9.1. Key Findings
    9.2. Market Value Forecast, by Region
        9.2.1. Asia Pacific
        9.2.2. Latin America
        9.2.3. Middle East & Africa
        9.2.4. Rest of the World
    9.3. Market Attractiveness, by Country/Region

10. Asia Pacific Foot and Mouth Disease Vaccine Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast, by Type, 2017-2031
        10.2.1. Aluminum Hydroxide and Saponin Vaccines
        10.2.2. Oil-based Vaccines
            10.2.2.1. Single-oil Emulsion
            10.2.2.2. Double-oil Emulsion
    10.3. Market Value Forecast, by Animal, 2017-2031
        10.3.1. Cattle
        10.3.2. Sheep and Goat
        10.3.3. Swine/Pig
        10.3.4. Others
    10.4. Market Value Forecast, by Distribution Channel, 2017-2031
        10.4.1. Veterinary Clinics
        10.4.2. Government Institutions
        10.4.3. Others
    10.5. Market Value Forecast, by Country/Sub-region, 2017-2031
        10.5.1. China
        10.5.2. India
        10.5.3. Rest of Asia Pacific
    10.6. Market Attractiveness Analysis
        10.6.1. By Type
        10.6.2. By Animal
        10.6.3. By Distribution Channel
        10.6.4. By Country/Sub-region

11. Latin America Foot and Mouth Disease Vaccine Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Type, 2017-2031
        11.2.1. Aluminum Hydroxide and Saponin Vaccines
        11.2.2. Oil-based Vaccines
            11.2.2.1. Single-oil Emulsion
            11.2.2.2. Double-oil Emulsion
    11.3. Market Value Forecast, by Animal, 2017-2031
        11.3.1. Cattle
        11.3.2. Sheep and Goat
        11.3.3. Swine/Pig
        11.3.4. Others
    11.4. Market Value Forecast, by Distribution Channel, 2017-2031
        11.4.1. Veterinary Clinics
        11.4.2. Government Institutions
        11.4.3. Others
    11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
        11.5.1. Brazil
        11.5.2. Argentina
        11.5.3. Rest of Latin America
    11.6. Market Attractiveness Analysis
        11.6.1. By Type
        11.6.2. By Animal
        11.6.3. By Distribution Channel
        11.6.4. By Country/Sub-region

12. Middle East & Africa Foot and Mouth Disease Vaccine Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Type, 2017-2031
        12.2.1. Aluminum Hydroxide and Saponin Vaccines
        12.2.2. Oil-based Vaccines
            12.2.2.1. Single-oil Emulsion
            12.2.2.2. Double-oil Emulsion
    12.3. Market Value Forecast, by Animal, 2017-2031
        12.3.1. Cattle
        12.3.2. Sheep and Goat
        12.3.3. Swine/Pig
        12.3.4. Others
    12.4. Market Value Forecast, by Distribution Channel, 2017-2031
        12.4.1. Veterinary Clinics
        12.4.2. Government Institutions
        12.4.3. Others
    12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
        12.5.1. GCC Countries
        12.5.2. South Africa
        12.5.3. Rest of Middle East & Africa
    12.6. Market Attractiveness Analysis
        12.6.1. By Type
        12.6.2. By Animal
        12.6.3. By Distribution Channel
        12.6.4. By Country/Sub-region
13. Rest of the World Foot and Mouth Disease Vaccine Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Type, 2017-2031
        13.2.1. Aluminum Hydroxide and Saponin Vaccines
        13.2.2. Oil-based Vaccines
            13.2.2.1. Single-oil Emulsion
            13.2.2.2. Double-oil Emulsion
    13.3. Market Value Forecast, by Animal, 2017-2031
        13.3.1. Cattle
        13.3.2. Sheep and Goat
        13.3.3. Swine/Pig
        13.3.4. Others
    13.4. Market Value Forecast, by Distribution Channel, 2017-2031
        13.4.1. Veterinary Clinics
        13.4.2. Government Institutions
        13.4.3. Others
    13.5. Market Attractiveness Analysis
        13.5.1. By Type
        13.5.2. By Animal
        13.5.3. By Distribution Channel
14. Competition Landscape
    14.1. Market Player - Competition Matrix (By Tier and Size of companies)
    14.2. Company Profiles
        14.2.1. BVI
            14.2.1.1. Company Overview
            14.2.1.2. Financial Overview
            14.2.1.3. Product Portfolio
            14.2.1.4. Business Strategies
            14.2.1.5. Recent Developments
        14.2.2. Indian Immunologicals Ltd.
            14.2.2.1. Company Overview
            14.2.2.2. Financial Overview
            14.2.2.3. Product Portfolio
            14.2.2.4. Business Strategies
            14.2.2.5. Recent Developments
        14.2.3. Ceva Sant? Animale
            14.2.3.1. Company Overview
            14.2.3.2. Financial Overview
            14.2.3.3. Product Portfolio
            14.2.3.4. Business Strategies
            14.2.3.5. Recent Developments
        14.2.4. MEVAC
            14.2.4.1. Company Overview
            14.2.4.2. Financial Overview
            14.2.4.3. Product Portfolio
            14.2.4.4. Business Strategies
            14.2.4.5. Recent Developments
        14.2.5. National Veterinary Institute
            14.2.5.1. Company Overview
            14.2.5.2. Financial Overview
            14.2.5.3. Product Portfolio
            14.2.5.4. Business Strategies
            14.2.5.5. Recent Developments
        14.2.6. Limor de Colombia SAS
            14.2.6.1. Company Overview
            14.2.6.2. Financial Overview
            14.2.6.3. Product Portfolio
            14.2.6.4. Business Strategies
            14.2.6.5. Recent Developments
        14.2.7. Brilliant Bio Pharma
            14.2.7.1. Company Overview
            14.2.7.2. Financial Overview
            14.2.7.3. Product Portfolio
            14.2.7.4. Business Strategies
            14.2.7.5. Recent Developments
        14.2.8. VETAL Animal Health Products, Inc.
            14.2.8.1. Company Overview
            14.2.8.2. Financial Overview
            14.2.8.3. Product Portfolio
            14.2.8.4. Business Strategies
            14.2.8.5. Recent Developments
        14.2.9. Biog?nesis Bag?
            14.2.9.1. Company Overview
            14.2.9.2. Financial Overview
            14.2.9.3. Product Portfolio
            14.2.9.4. Business Strategies
            14.2.9.5. Recent Developments
        14.2.10. Kenya Veterinary Vaccines Production Institute
            14.2.10.1. Company Overview
            14.2.10.2. Financial Overview
            14.2.10.3. Product Portfolio
            14.2.10.4. Business Strategies
            14.2.10.5. Recent Developments
        14.2.11. Boehringer Ingelheim International GmbH
            14.2.11.1. Company Overview
            14.2.11.2. Financial Overview
            14.2.11.3. Product Portfolio
            14.2.11.4. Business Strategies
            14.2.11.5. Recent Developments
        14.2.12. Zoetis, Inc.
            14.2.12.1. Company Overview
            14.2.12.2. Financial Overview
            14.2.12.3. Product Portfolio
            14.2.12.4. Business Strategies
            14.2.12.5. Recent Developments
        14.2.13. Ourofino Sa?de Animal
            14.2.13.1. Company Overview
            14.2.13.2. Financial Overview
            14.2.13.3. Product Portfolio
            14.2.13.4. Business Strategies
            14.2.13.5. Recent Developments



List of Figures

List of Figures

Figure 01: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, 2017-2031

Figure 02: Foot and Mouth Disease Vaccine Market Value Share, by Type, 2022

Figure 03: Foot and Mouth Disease Vaccine Market Value Share, by Animal, 2022

Figure 04: Foot and Mouth Disease Vaccine Market Value Share, by Distribution Channel, 2022

Figure 05: Global Foot and Mouth Disease Vaccine Market Value Share Analysis, by Type, 2022 and 2031

Figure 06: Global Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Type, 2023-2031

Figure 07: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn), by Aluminum Hydroxide and Saponin Vaccines, 2017?2031

Figure 08: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn), by Oil-based Vaccines, 2017?2031

Figure 09: Global Foot and Mouth Disease Vaccine Market Value Share Analysis, by Animal, 2022 and 2031

Figure 10: Global Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Animal, 2023-2031

Figure 11: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Cattle, 2017-2031

Figure 12: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Sheep and Goat, 2017-2031

Figure 13: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Swine/Pig, 2017-2031

Figure 14: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Others, 2017-2031

Figure 15: Global Foot and Mouth Disease Vaccine Market Value Share Analysis, by Distribution Channel, 2022 and 2031

Figure 16: Global Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Distribution Channel, 2023-2031

Figure 17: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Veterinary Clinics, 2017-2031

Figure 18: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Government Institutions, 2017-2031

Figure 19: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Others, 2017-2031

Figure 20: Global Foot and Mouth Disease Vaccine Market Value Share Analysis, by Region, 2022 and 2031

Figure 21: Global Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Region, 2023-2031

Figure 22: Asia Pacific Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, 2017-2031

Figure 23: Asia Pacific Foot and Mouth Disease Vaccine Market Value Share Analysis, by Type, 2022 and 2031

Figure 24: Asia Pacific Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Type, 2023-2031

Figure 25: Asia Pacific Foot and Mouth Disease Vaccine Market Value Share Analysis, by Animal, 2022 and 2031

Figure 26: Asia Pacific Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Animal, 2023-2031

Figure 27: Asia Pacific Foot and Mouth Disease Vaccine Market Value Share Analysis, by Distribution Channel, 2022 and 2031

Figure 28: Asia Pacific Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Distribution Channel, 2023-2031

Figure 29: Asia Pacific Foot and Mouth Disease Vaccine Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 30: Asia Pacific Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

Figure 31: Latin America Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, 2017-2031

Figure 32: Latin America Foot and Mouth Disease Vaccine Market Value Share Analysis, by Type, 2022 and 2031

Figure 33: Latin America Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Type, 2023-2031

Figure 34: Latin America Foot and Mouth Disease Vaccine Market Value Share Analysis, by Animal, 2022 and 2031

Figure 35: Latin America Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Animal, 2023-2031

Figure 36: Latin America Foot and Mouth Disease Vaccine Market Value Share Analysis, by Distribution Channel, 2022 and 2031

Figure 37: Latin America Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Distribution Channel, 2023-2031

Figure 38: Latin America Foot and Mouth Disease Vaccine Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 39: Latin America Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

Figure 40: Middle East & Africa Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, 2017-2031

Figure 41: Middle East & Africa Foot and Mouth Disease Vaccine Market Value Share Analysis, by Type, 2022 and 2031

Figure 42: Middle East & Africa Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Type, 2023-2031

Figure 43: Middle East & Africa Foot and Mouth Disease Vaccine Market Value Share Analysis, by Animal, 2022 and 2031

Figure 44: Middle East & Africa Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Animal, 2023-2031

Figure 45: Middle East & Africa Foot and Mouth Disease Vaccine Market Value Share Analysis, by Distribution Channel, 2022 and 2031

Figure 46: Middle East & Africa Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Distribution Channel, 2023-2031

Figure 47: Middle East & Africa Foot and Mouth Disease Vaccine Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 48: Middle East & Africa Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

Figure 49: Rest of the World Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, 2017-2031

Figure 50: Rest of the World Foot and Mouth Disease Vaccine Market Value Share Analysis, by Type, 2022 and 2031

Figure 51: Rest of the World Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Type, 2023-2031

Figure 52: Rest of the World Foot and Mouth Disease Vaccine Market Value Share Analysis, by Animal, 2022 and 2031

Figure 53: Rest of the World Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Animal, 2023-2031

Figure 54: Rest of the World Foot and Mouth Disease Vaccine Market Value Share Analysis, by Distribution Channel, 2022 and 2031

Figure 55: Rest of the World Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Distribution Channel, 2023-2031

List of Tables

List of Tables

Table 01: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Type, 2017-2031

Table 02: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Oil-based Vaccines, 2017-2031

Table 03: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Animal, 2017-2031

Table 04: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031

Table 05: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Region, 2017-2031

Table 06: Asia Pacific Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Type, 2017-2031

Table 07: Asia Pacific Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Oil-based Vaccines, 2017-2031

Table 08: Asia Pacific Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Animal, 2017-2031

Table 09: Asia Pacific Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031

Table 10: Asia Pacific Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031

Table 11: Latin America Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Type, 2017-2031

Table 12: Latin America Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Oil-based Vaccines, 2017-2031

Table 13: Latin America Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Animal, 2017-2031

Table 14: Latin America Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031

Table 15: Latin America Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031

Table 16: Middle East & Africa Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Type, 2017-2031

Table 17: Middle East & Africa Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Oil-based Vaccines, 2017-2031

Table 18: Middle East & Africa Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Animal, 2017-2031

Table 19: Middle East & Africa Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031

Table 20: Middle East & Africa Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031

Table 21: Rest of the World Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Type, 2017-2031

Table 22: Rest of the World Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Oil-based Vaccines, 2017-2031

Table 23: Rest of the World Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Animal, 2017-2031

Table 24: Rest of the World Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031